February 2, 2012
Mitt versus Newt Re "Florida win won't seal race," Feb. 1 Why is Mitt Romney smiling in your front-page photograph? In order to win Florida, he apparently had to lavishly outspend the thrice-married ex-House speaker whose second wife recently went public with new details of his adultery with the lady who succeeded her. Romney's may be a victory, but it's pyrrhic at best and does not speak well for his ability to prevail going...
October 23, 1996 |
Major drug companies on Tuesday reported generally stronger-than-expected earnings, led by Eli Lilly, which showed continued gains in sales of the antidepressant Prozac. If last year's profit from Indianapolis-based Lilly's medical devices unit, which has been spun off, is excluded, the company's net income would have improved 33%. The company earned $415.6 million, or 76 cents per share, during the period ended Sept. 30, compared with $1.23 billion, or $2.14 share, during the 1995 quarter.
January 29, 1997 |
Speedy government approval of new drugs, rising demand from HMOs and stable or increasing prices are all helping the pharmaceutical industry post double-digit profit increases. Of nine major U.S. drug makers that have reported fourth-quarter earnings this month, the average gain is 20%. Merck & Co., American Home Products Corp. and Warner-Lambert Co. all beat analyst predictions with their reports Tuesday. Merck, based in Whitehouse Station, N.J., boosted net earnings 22% to $1.
January 15, 2001 |
A group of more than 40 drug companies is taking the South African government to court in a bid to stop the uncontrolled importation or manufacture of cut-price versions of patented AIDS drugs, officials said. The action, brought by the South African pharmaceutical manufacturers association on behalf of its members, will be heard in the Pretoria High Court on March 5, bringing to a head a three-year intellectual property dispute.
CALIFORNIA | LOCAL
August 26, 2005 |
California accused GlaxoSmithKline, Abbott Laboratories and 37 other pharmaceutical companies of defrauding the state's $34-billion Medi-Cal health program for the poor by inflating prescription drug prices. In a lawsuit filed Thursday in federal court in Boston, California Atty. Gen. Bill Lockyer said the companies supplied inflated prices to industry publications used by Medi-Cal to reimburse healthcare providers for drug costs.
August 10, 2000 |
A sell-off in shares of big drug companies dragged down blue-chip stocks Wednesday in the wake of a court ruling that could speed up the sale of a generic version of the antidepressant drug Prozac in the United States. The broader market, however, fared relatively well, though share prices in general pulled back from their highs. In commodity trading, crude oil futures surged in the wake of surprising data Tuesday showing that U.S. inventories are at 24-year lows.